Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433557
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-05-23
Brief Title:
A Phase 2 Clinical Trial to Evaluate Efficacy Safety and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
Sponsor:
Ascendis Pharma Growth Disorders AS
Organization:
Ascendis Pharma AS
Organization Data
Organization:
Ascendis Pharma AS
Class:
INDUSTRY
Study ID:
ASND0042
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascendis Pharma Growth Disorders AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None